Abstract
Treatment of cutaneous leishmaniasis is sometimes difficult. No single ideal therapy has yet been identified and some of the drugs that are currently used are associated with significant toxicity. We present two cases of cutaneous leishmaniasis in children, one caused by Leishmania infantum and the other by Leishmania braziliensis. Both of them were successfully treated with intravenous liposomal amphotericin B.
MeSH terms
-
Amphotericin B / administration & dosage*
-
Antiprotozoal Agents / administration & dosage*
-
Child
-
Humans
-
Infant
-
Leishmania braziliensis / drug effects*
-
Leishmania infantum / drug effects*
-
Leishmaniasis, Cutaneous / drug therapy*
-
Leishmaniasis, Cutaneous / parasitology
-
Leishmaniasis, Cutaneous / pathology
-
Liposomes
-
Male
-
Polymerase Chain Reaction
-
Treatment Outcome
Substances
-
Antiprotozoal Agents
-
Liposomes
-
Amphotericin B